Pfizer, BioNTech plan filing as vaccine proves 95% effective
by from on (#5AHJJ)
(Bloomberg) -- Pfizer Inc. said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days.